Title : Chronic myelomonocytic leukemia with double-mutations in DNMT3A and FLT3-ITD treated with decitabine and sorafenib.

Pub. Date : 2017 Nov 2

PMID : 28102729






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Chronic myelomonocytic leukemia with double-mutations in DNMT3A and FLT3-ITD treated with decitabine and sorafenib. Decitabine fms related receptor tyrosine kinase 3 Homo sapiens
2 We reported a 51-year-old man who had CMML with concomitant mutations in DNMT3A and FLT3-ITD.The patient received decitabine and sorafenib combined treatment. Decitabine fms related receptor tyrosine kinase 3 Homo sapiens